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Coxiella burnetii is an obligate intracellular pathogen
known to be the causative agent of Q fever, a zoonosis with a
worldwide occurrence (1). The organism has been found in
many wild and domestic animals (1-3). The most common
reservoirs of infection in humans are domestic farm animals
such as cattle, goats, and sheep (4-6). C. burnetii is shed in
urine, feces, and milk from infected animals and has a
particularly high concentration in products of conception (7).
The organism is highly infectious: Only one organism is
required to produce infection under experimental conditions
(8,9). Inhalation of aerosolized microorganisms is thought to
be the most important route of infection in humans. However,
ingestion of raw milk products has also been implicated (6).
Although C. burnetii can cause abortion and stillbirth,
most animals have a persistent, relatively asymptomatic
subclinical infection (10). Infection in humans usually
manifests as a self-limiting febrile illness, pneumonia, or
hepatitis (11). Most patients have an uneventful recovery;
however, chronic infections such as Q-fever endocarditis and
chronic hepatitis are uncommon but well-documented
sequelae (12).
The diagnosis of Q fever is usually established by
demonstrating seroconversion to Coxiella antigens in
conjunction with an appropriate clinical history (13).
C. burnetii can have two distinct antigenic presentations or
phases; animals and humans develop antibody responses to
both phases. In humans, phase II gives rise to the
predominant antibody response in acute infection, while
response to phase I antigen is dominant during chronic
infections (14).
In the spring of 1999, abortions were noted in goats on one
farm belonging to a newly formed cooperative in rural
Newfoundland. Aborted placenta had histologic evidence of C.
burnetii infection. At the same time a number of farmers and
their workers had a nonspecific febrile illness associated with
severe headaches. Serologic testing revealed that these
persons had recent infection with C. burnetii. No documented
case of Q fever had previously been reported in
Newfoundland. An epidemiologic investigation and serologic
survey were started in April 1999 to determine the extent of
the outbreak in animals and humans, the nature of the
clinical illness, and risk factors for Q fever associated with
this outbreak.
Methods
Identification of Cases
The cooperative consisted of eight goat farms within a
170-km2 area of rural Newfoundland, with a population of
approximately 8,000 people (Figure 1). In April 1999,
farmers, workers, and contacts (family members of the
farmers or workers and other persons who may have had
contact with the farms) were interviewed by using a detailed
questionnaire.  Workers included persons who were involved
directly with animal care as well as carpenters and other farm
laborers. Serum samples were drawn to determine the presence
of antibodies to C. burnetii. Family physicians in the area
submitted serum samples from all patients in their practices
who had been seen with symptoms compatible with Q fever.
The diagnosis of acute C. burnetii infection in
participants was based solely on serologic findings as
Goat-Associated Q Fever: A New Disease
in Newfoundland
Todd F. Hatchette,* Robert C. Hudson,† Walter F. Schlech,*
Nancy A. Campbell,* Jill E. Hatchette,* Sam Ratnam,‡ Didier Raoult,§
Catherine Donovan,‡ and Thomas J. Marrie¶
*Dalhousie University, Halifax, Nova Scotia, Canada; †Newfoundland Department of Forest
Resources and Agrifoods, Clarenville, Newfoundland, Canada; ‡Memorial University of
Newfoundland, St. John’s, Newfoundland, Canada; §Unite des Rickettsies, Marseille, France;
and ¶University of Alberta, Edmonton, Alberta, Canada
Address for correspondence: TJ Marrie, Department of Medicine,
University of Alberta, 2F1.30 Walter C. Mackenzie Health Sciences
Centre, 8440 – 112 St. Edmonton, Alberta T6G 2R7, Canada; fax: 780-
407-3132; email: tom.marrie@ualberta.ca
In the spring of 1999 in rural Newfoundland, abortions in goats were associated
with illness in goat workers. An epidemiologic investigation and a serologic
survey were conducted in April 1999 to determine the number of infections,
nature of illness, and risk factors for infection. Thirty-seven percent of the
outbreak cohort had antibody titers to phase II Coxiella burnetii antigen >1:64,
suggesting recent infection. The predominant clinical manifestation of Q fever
was an acute febrile illness. Independent risk factors for infection included
contact with goat placenta, smoking tobacco, and eating cheese made from
pasteurized goat milk. This outbreak raises questions about management of
such outbreaks, interprovincial sale and movement of domestic ungulates, and
the need for discussion between public health practitioners and the dairy
industry on control of this highly infectious organism.414 Emerging Infectious Diseases Vol. 7, No. 3, May–June 2001
Research
described below. In July 1999, follow-up serum samples were
obtained to determine further evidence of seroconversion. In
addition, 2 weeks earlier, serum was collected from 154
volunteers from adjacent communities (community cohort)
and a questionnaire was completed for comparison with the
outbreak cohort.
Serum samples were collected in May 1999 from 387
random blood donors, primarily from urban areas. These
samples were used to determine the background seropreva-
lence of C. burnetii infection in Newfoundland.
Source of Animals and Identification of
C. burnetii Infection in Animals
Although a few locally raised goats were present in the
community before the cooperative was established, the eight
farms received shipments of goats from Ontario, Nova Scotia,
Prince Edward Island, and Maine in the summer and fall of
1998. At the time of the outbreak, 174 goats were within the
cooperative, with 10 to 38 animals per herd. Serum samples
were obtained from 147 goats to determine the extent of
C. burnetii infections in the animals.
Serum samples were collected from livestock from
other farms throughout Newfoundland to determine the
background seroprevalence of Q fever in farm animals in
Newfoundland.
Laboratory Studies
Antibody titers (immunoglobulin G [IgG]) to C. burnetii
phase I and phase II antigens were determined (15).
Antibodies were detected by using indirect immunofluores-
cence with whole cells of the Nine-Mile strain of C. burnetii.
An IgG antibody titer of >1:8 was considered seropositive,
indicating prior exposure to C. burnetii. Acute C. burnetii
infection was characterized by a phase II IgG titer of 1:64 or a
fourfold rise in titer between two separate serum samples.
Placenta samples from goats were sent to Dr. D. Raoult in
France, where they were processed for polymerase chain
reaction (PCR) using established protocols (16).
Epidemiologic Studies
A standardized questionnaire was administered to
participants who submitted a serum sample. Demographic
data, a detailed history of exposure to goats, clinical history,
and symptoms were collected by direct interview. Where
available, charts of patients were reviewed to collect
additional clinical and laboratory data.
To construct epidemic curves, date of onset of symptoms
was considered the date of infection. When this date was
unavailable (in asymptomatic cases and participants lacking
clinical data), date of infection was based on date of the first
serum sample (if it had a diagnostic titer) or the halfway point
in those who demonstrated a fourfold rise in antibody titer
between acute- and convalescent-phase serum samples.
Statistical Analysis
Differences between infected and uninfected participants
were tested for statistical significance by using the chi-square
test for proportions and Student t test for means. Independent
risk factors for infection were determined by using a
backward logistical regression analysis. Variables with a
p value of <0.05 on univariate analysis were entered into the
regression analysis. All data were analyzed by using SPSS for
Windows version 8.0 (SPSS Inc. 1989-1999); results were
considered significant when p was <0.05.
Results
Clinical Illness in Goats and Humans
Kidding began January 6 and ended April 24, 1999.
Although occasionally it was restricted to dedicated pens,
most birthing took place in a communal pen on each farm.
Coxiella was identified in placental samples examined by
using electron microscopy and light microscopy (Gimenez
stain), and C. burnetii DNA was demonstrated in all three
placental samples with PCR. A total of 30 abortions were
recorded at six of the eight farms. (Some farms had incomplete
records.) The first abortion occurred in December before the
kidding season began; the others took place between January
14 and April 24, with abortion rates of 16%-22% per farm.
There was no relationship between seropositivity in goats and
frequency of abortion.
The epidemic curves differed from farm to farm. Evidence
of a continuous common source of infection was seen at one
farm (Figure 2), while other evidence suggested a point source
(Figure 3). The overall epidemic curve suggested a continuous
Figure 1. Map of the Newfoundland goat cooperative showing the
farms (2-9) in relationship to the surrounding communities (A-D, the
area from which the community cohort was derived). (Note: farm 1 is
not directly involved with the cooperative.)Vol. 7, No. 3, May–June 2001 Emerging Infectious Diseases 415
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source or reservoir for infection that had a peak during the
kidding season (Figure 4).
Illness in goat farmers or their workers was noted in
March 1999. Serologic data were available for 179 farmers,
workers, and contacts (outbreak cohort). Eighty (44.7%)
outbreak cohort participants had antibodies against the
phase II antigen. Sixty-six (36.9%) had phase II titers of >1:64
or had a fourfold rise in titer, suggesting recent infection
(Figure 5). The seroprevalence of infected workers (including
farmers) on each farm ranged from 0 (farm 5) to 87.5% (farm
4). In comparison, 35 (22.7%) of 154 community cohort
participants were seropositive (p<0.001), and 2 (1.3%) had
titers of antibodies to phase II antigen of >1:64 (Figure 6).
Seroprevalence in blood donors (8.3%) (Table 1) was
significantly lower than that of the control (p<0.001) and
outbreak (p<0.001) cohorts. Five blood donors (1.3%) had
titers to phase II antigen >1:64.
Questionnaires were completed by 146 (81.6%) farm
workers or contacts who provided blood samples. The
remaining 33 could not be reached for questioning. Of the 146
participants, 9 (6.2%) were farmers, 58 (39.7%) were workers,
and 79 (54.1%) were contacts. Demographic data were
collected (Table 2). The infected and noninfected groups had
equal numbers of men and women. Infected persons tended to
be slightly older, were more likely to have been ill in the past
2 months (odds ratio [OR] 3.53), and to have visited their
doctor during that time (OR 3.13). Symptoms associated with
infection included sweats, chills, headache, weight loss,
malaise, fever, fatigue, myalgias, dyspnea, nausea, and
diarrhea (Table 2).
The incubation period for Q fever was difficult to
determine as most people had many contacts with goats.
However, three persons could recall the date of a specific high-
risk activity such as assisting with the delivery of a stillborn
kid. Incubation periods for these three persons were 21, 31,
and 36 days.
A family physician performed clinical laboratory tests on
25 of the infected persons. Four (16%) of these had
transaminase levels >1.5x, the upper limit of normal. Eight
had X rays; one had pneumonia.
Figure 2. Epidemic curve for farm no. 4, showing the timing of human
infection with kidding and abortions.
Figure 3. Epidemic curve from farm no. 6, showing the timing of
human infection with kidding and abortions.
Figure 4. Overall epidemic curve for Q fever outbreak associated with
Newfoundland goat cooperative.
Figure 5. Antibody titers to Coxiella burnetii phase II antigen in the
outbreak cohort. Of the infected cohort, 24/66 had a fourfold rise in
antibodies to phase II (24/66 of the infected cohort had a fourfold rise
in antibodies to phase II antigen)416 Emerging Infectious Diseases Vol. 7, No. 3, May–June 2001
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Risk Factors for Q Fever
Risk factors associated with human infection on
univariate analysis included being a farmer, milking goats,
assisting with kidding, handling placentas, shoveling
manure, having direct contact with goats, eating cheese made
from goat milk, petting goats, feeding goats, being a worker,
smoking tobacco, and drinking alcohol (Table 3). When only a
multivariate analysis was used, the following were
significant risk factors for infection with C. burnetii: contact
with the placenta (p<0.001), smoking history (p=0.001),
and eating cheese made from goat milk (p= 0.022). Both
infected persons in the community cohort also had direct
contact with goats.
Overall, 82 (55.8%) of the 147 goats were seropositive
(range from 10% to 100%, depending on the farm); antibody
titers ranged from 1:8 to >1:4,096. Although 8 (50%) of 16
goats from other areas in eastern Newfoundland had
antibodies to C. burnetii, the highest titer was 1:16. In
contrast, titers in goats in the outbreak ranged from 1:8 to
>1:4,096. In the goats in the cooperative, 63 (43%) and 30
(20%), respectively, had an antibody titer of >1:64 to phase I
and phase II antigen. Correlation between C. burnetii
infection in goats and the geographic origin of the animals or
determination of a relationship between seropositivity of
goats and the number of persons infected on each farm was
not feasible because of insufficient data.
Figure 6. Antibody titers to Coxiella burnetii phase II antigen in the
community cohort.
Table 1. Seroprevalance of antibodies to Coxiella burnetii phase II
antigen in random blood donors from Newfoundland
Region Seropositivity no. (%)
St. John’s Center 12/155 (7.7)
Cornerbrook  1/31    (3.2)
St. John’s  7/57    (12.3)
Norman’s Cove  4/40    (10.0)
Foxtrap  6/71    (8.5)
Conception Bay Central  2/33    (6.1)
Total 32/387 (8.3)
Table 2. Demographic features and symptoms associated with human
Coxiella burnetii infection in Newfoundland outbreak
Features and   Infected Noninfected      Odds ratio
symptoms     no. (%)     no. (%)       (95% CI)
Male 31/58 (53.4) 46/88 (52.3)  1.05 (0.154-2.04)
Female 27/58 (46.6) 42/88 (47.7)
Mean age 38.48±11.76 33.47±19.34  p=0.054
Sick in the past 49/60 (81.7) 48/86 (55.8)  3.53 (1.62–7.70)
  2 months
Symptoms
  Sweats 11/12 (91.7)   3/9   (33.3) 22.0  (1.86–260.5)
  Chills 12/14 (85.7)   4/10 (40.0)  9.00 (1.27–63.90)
  Headache 43/60 (71.7) 20/78 (25.6)  7.34 (3.44–15.64)
  Malaise 44/59 (74.6) 28/77 (36.4)  5.13 (2.43–10.84)
Weight loss  8/31  (25.8)   3/43 (7.0)  4.64 (1.12–19.24)
Fever 40/60 (66.7) 25/79 (31.6)  4.32 (2.11–8.84)
Fatigue 39/58 (67.2) 27/79 (34.2)  3.95 (1.93–8.11)
Myalgias 26/58 (44.8) 15/76 (19.7)  3.30 (1.54–7.11)
Dyspnea 19/60 (31.7) 12/78 (15.4)  2.55 (1.12–5.79)
Nausea 30/60 (50.0) 22/80 (27.5)  2.24 (1.30–5.34)
Diarrhea 23/60 (38.3) 18/81 (22.2)  2.18 (1.04–4.55)
Cognitivea 14/30 (46.7)   4/15 (26.7)  2.41 (0.62–9.29)
Sputum 13/46 (22.0) 11/78 (14.1)  1.72 (0.71–4.18)
EOM pain  8/15  (53.3)   4/9   (44.4)  1.43 (0.27–7.52)
Neck stiffness 16/22 (72.7)   9/14 (64.3)  1.43 (0.27–7.52)
Vomiting 12/60 (20.0) 15/81 (18.5)  1.10 (0.47–2.56)
Pleuritic pain  8/57  (14.0) 10/76 (13.2)  1.08 (0.40–2.93)
Cough 22/60 (36.7) 28/81 (34.6)  1.10 (0.55–2.20)
Loss of libido 13/32 (40.6)   5/12 (41.7)  0.96 (0.25–3.38)
aCognitive problems, including changes in concentration, memory, or temper.
EOM, extra-ocular eye movement; CI, confidence intervals.
Table 3. Exposure risks associated with Coxiella burnetii infection in the
Newfoundland outbreak
   Infected Noninfected     Odds ratio
Risk factors      no.(%)     no.(%)       (95% CI)
Visited a barn 57/60 (95.0) 63/86 (73.3)  6.94 (1.98–24.34)
Direct contact 54/60 (90.0) 54/86 (62.8)  5.33 (2.06–13.79)
  with goats
Milking 19/60 (31.7)  3/85  (3.5) 12.67 (3.54–45.29)
Assisting with 29/60 (48.3)  6/85  (7.1) 12.32 (4.66–32.57)
 kidding
Handling placentaa 31/60 (51.6)  7/86  (8.1) 12.06 (4.79–30.39)
Shoveling manure 37/60 (61.7) 19/84 (22.6)  5.50  (2.65–11.41)
Feeding 39/57 (68.4) 29/85 (34.2)  4.17  (2.06–8.43)
Petting goatsa 52/60 (86.7) 51/85 (60.0)  4.33  (1.83–10.26)
Farmer  8/60  (13.3)  1/85  (1.2) 12.92 (1.57–106.32)
Farm worker 34/60 (56.7) 24/86 (27.9)  3.38  (1.67-6.77)
Household contact, 13/60 (21.7) 35/85 (41.2)  0.40  (0.19-0.84)
  visited farm
Household contact,  2/60  (3.3) 23/85 (27.1)  0.09  (0.02–0.41)
 no farm visit
Ate goat cheesea 17/60 (28.3)  6/86  (7.0)  5.27  (1.94–14.35)
Smokeda 36/58 (62.1) 28/84 (33.3)  3.27  (1.63–6.58)
Drank alcohol 37/57 (64.9) 38/84 (45.2)  2.08  (1.04–4.13)
Have liver  5/53  (9.4)  2/72  (2.8)  3.65  (0.68-19.57)
  problems
Have cats 25/59 (42.4) 30/86 (34.9)  1.37  (0.70–2.71)
Drink goat milk 19/60 (31.7) 27/86 (31.4)  1.01  (0.50–2.06)
aBy logistic regression model, the following were statistically significant:
Contact with placenta (p <0.001); smoking history (p=0.001); eating goat
cheese (p=0.022); and petting goats (p=0.055).Vol. 7, No. 3, May–June 2001 Emerging Infectious Diseases 417
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Conclusion
Goats have been implicated in outbreaks of Q fever in the
United States, Ontario, Bulgaria, Slovakia, Greece, and
Australia, and have replaced sheep and cattle as the most
common source of human infection with C. burnetii in
Bulgaria (17-19). An estimated 20% of Ontario’s dairy goat
population have antibodies to C. burnetii (20).
The incubation period and clinical illness seen in the
Newfoundland outbreak were consistent with those reported
for other outbreaks (5,15,21,22). The most common
manifestation of C. burnetii infection was an acute febrile
illness. Although dyspnea was an associated feature of our
outbreak, only one of eight patients with X rays had
pneumonia. This is in contrast to what is typically seen in
Nova Scotia, where C. burnetii pneumonia is common after
exposure to infected parturient cats (15,23).
Although the patients reported here are the first
documented cases of Q fever in Newfoundland, serologic
results from blood donors suggest that infection with this
organism is present elsewhere in this province but goes
unrecognized. The seroprevalence of C. burnetii in
Newfoundland blood donors (8.3%) is consistent with results
from blood donors in other Atlantic Canadian provinces
(24,25). The higher seroprevalence in the population from
communities surrounding the outbreak area (22.7%) could
be due to their close proximity to the outbreak area or may
reflect a difference in prevalence, which is often higher in
rural areas (11).
The eight farms in the cooperative house their goats in
small, uninsulated, naturally ventilated barns, many of
which have concrete floors. The winter and spring months in
Newfoundland can be quite cold, so to provide better
insulation the hay spread on floors of the pens is packed down
instead of being disposed of regularly. The resulting “manure
pack” would be heavily contaminated by C. burnetii in feces,
urine, and products of conception. Removing the bedding
would generate aerosols containing C. burnetii. Coxiella is
very hardy and resists desiccation, remaining viable in soil for
several years (26).
Contaminated hay and manure were also spread on the
rocky ground to fertilize small pastures next to the barns.
This method of disposal represents potential sources of
exposure for surrounding communities. Inhalation of
C. burnetii from contaminated environments is well
documented, and contaminated fields and roads often serve as
reservoirs for airborne spread of C. burnetii (5,18,22,27,28).
Studies from Europe demonstrate that wind can spread
C. burnetii >18 km from its source (29). These newly developed
pastures in the Newfoundland cooperative may explain the
higher seroprevalence rate in the community cohort compared
with that in blood donors from across the province.
Kidding took place in isolated pens but also occurred in
communal areas of the barn. Placental tissue and aborted
kids were disposed of by incineration or burial. Although the
workers usually did not handle the placenta, they would often
help clean and dry newborn goats covered in amniotic fluid
without the protection of masks or gloves. Exposure to the
birth products of infected animals has been consistently
shown to be a risk factor in other Q fever outbreaks (28). Given
that Coxiella is shed in high numbers in birth products (7) and
aerosolization of the microorganism can persist for days after
parturition, despite immediate removal of the highly
infectious placenta (30), it is not surprising that exposure to
the placenta was an independent risk factor for infection
(p<0.001).
In our study, smoking tobacco was an independent risk
factor for infection (p=0.001). This could be due to
contaminated hands touching cigarettes, resulting in
ingestion of Coxiella. Smoking does impair pulmonary host
defenses and thus may have contributed to this finding (31).
In addition, some barns did not have running water and
washrooms until late in the spring, contributing to poor
hygienic practices in some instances.
The role of drinking unpasteurized milk in C. burnetii
infection is controversial. C. burnetii has been recovered from
milk from infected cows and goats and from butter (17,32).
Epidemiologic studies suggest that ingestion of unpasteur-
ized milk has been a source of Coxiella infection for humans
(6,17,33). Experimental evidence to support a causal
relationship is sparse. Asymptomatic seroconversion and
infection were noted in inmates fed raw milk from a Q fever
infected herd (33). In another study, volunteers who drank
naturally infected unpasteurized milk did not develop
symptoms or an immunologic response to suggest infection
(34). These authors suggest that the lack of seroconversion in
their study may have been related to exposure to a different
Coxiella strain than the one that caused infection in the
inmate population (33,34). Pasteurization will effectively kill
Coxiella in raw milk (35). However, in our study, ingestion of
cheese made from pasteurized goat milk was identified as an
independent risk factor for infection (p=0.022) even though
consumption of goat milk itself was not associated with an
increased risk of infection (OR 1.07). This is the first time a
pasteurized dairy product has been implicated in an outbreak
of Q fever. However, 21 (14%) of 154 members of the
community cohort ate the product but were not infected. The
reason for the association between ingesting goat cheese and
developing Q fever is not clear and suggests further study is
needed. At present, this is an epidemiologic association only,
as C. burnetii has not been recovered from the goat cheese.
In Canada, C. burnetii infection is not a reportable
disease in animals (36). Serbezov (19) suggests that “goats
may pose a threat to human health as a source of C. burnetii
infection in every country in which they are raised extensively
and are in close contact with humans.” Goats in the
Newfoundland cooperative originated from four different
sources—Maine, Nova Scotia, Prince Edward Island, and
Ontario. Although the sale and movement of infected animals
have been implicated in spreading the disease (4), there was
no relationship between the seroprevalence rate of goats
originating from one area compared to another, making it
difficult to determine if one group of imported animals was
responsible for initiating the outbreak. However, goats tend
to remain chronically infected, and once infection is
established it can spread rapidly through the remaining
herds (37). Once C. burnetii infection was identified in the
herd, only four goats on one farm in the cooperative were
treated with antibiotics.
These are the first cases of Q fever in Newfoundland. The
small barns and poor ventilation created confined conditions418 Emerging Infectious Diseases Vol. 7, No. 3, May–June 2001
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and an environment that facilitated infection. Although
exposure to goats and eating unpasteurized milk have been
implicated in causing C. burnetii infection in the past, this is
the first time that a product made from pasteurized milk has
been associated epidemiologically as a risk factor. Outbreaks
of Q fever in research institutions as a result of exposure to
infected parturient sheep and goats has led to number of
recommendations (38-41). These recommendations include
using only C. burnetii-seronegative animals in research;
vaccinating seronegative animals; using protective clothing
and masks while working with animals (especially pregnant
ones); restricting access to animals; properly decontaminat-
ing surfaces with formalin or bleach solutions; properly
disposing of waste by incineration; and using caution, culling,
confinement, or chemotherapy in herds with a rate of >20%
seropositivity containing animals with titers >1:32.
Some of these measures are difficult to carry out on a
dairy farm; however, since data suggest that human infection
can be prevented by vaccination with formalin-inactivated
phase I C. burnetti, persons at risk from occupational
exposure should be offered the vaccine (41).
Our experience raises many questions about manage-
ment of C. burnetii outbreaks in the dairy industry, the
interprovincial sale and movement of domestic ungulates,
and the need for discussion between public health
practitioners and the dairy industry on control of this highly
infectious organism.
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